CD4 and myeloid sarcoma: Vitamin D supplementation has been shown to have anti‐inflammatory and immunomodulatory effects on the pathogenesis of MS by inhibiting the production of CD4+ T cells, thereby reducing the risk of MS and slowing disease progression [38].